Patients with type 2 diabetes who have diabetic dyslipidaemia or hypertriglyceridemia that cannot be managed with statins (lipid-lowering medications) alone are treated with Lipaglyn Tablet, an insulin sensitiser. Lipaglyn Tablet helps lower blood triglycerides and blood glucose levels because it contains a chemical that lowers both lipids and glucose. Increased triglyceride, low-density lipoprotein (LDL), and decreased high-density lipoprotein (HDL) levels are the hallmarks of diabetic dyslipidaemia. People who have type-2 diabetes mellitus frequently have this problem.
The medication “Saroglitazar,” which is found in Lipaglyn tablets, is a dual PPAR-α/γ agonist with a high PPAR-alpha and a moderate PPAR-gamma impact. PPAR-alpha promotes lipolysis and the hepatic oxidation of fatty acids while decreasing triglyceride production and secretion. Additionally, it causes HDL cholesterol production to rise. PPAR-gamma encourages the use of glucose and lessens the metabolic load on the liver and muscles. It enhances the suppression of hepatic glucose production caused by post-absorptive insulin. Consequently, Lipaglyn Tablets assist in reducing blood glucose and lipids.
Depending on your medical condition, you should take Lipaglyn Tablet for as long as your doctor has prescribed it. You might occasionally encounter certain typical side effects, including fever, dizziness, weakness, nausea, vomiting, and stomach inflammation. The majority of these side effects go away on their own with time and don’t need medical intervention. However, it is advised that you speak with your physician if these adverse effects become persistent.
If you are pregnant, speak with your physician. Nursing moms should refrain from using Lipaglyn Tablet since it is unknown if it is excreted into breastmilk. Children shouldn’t be given Lipaglyn tablets because their efficacy and safety have not been shown. Elderly people and those with liver or kidney disease should use Lipaglyn tablets with caution. Avoid drinking alcohol whilst using Lipaglyn Tablets as it may result in unpleasant side effects. Lipaglyn tablets may cause vertigo, therefore exercise caution when driving. To rule out any undesirable side effects, let your doctor know about your health and any of the medications you are taking. Management of Hypertriglyceridemia and Diabetic Dyslipidaemia When statins alone are unable to control diabetic dyslipidaemia or hypertriglyceridemia in type-2 diabetes, Lipaglyn Tablet, an insulin sensitiser, is administered. Triglycerides (TG), low-density lipoprotein (LDL), non-high-density lipoprotein (non-HDL), very low-density lipoprotein (VLDL), and HDL cholesterol have all been shown to decrease after taking Lipaglyn Tablet. By reducing fasting plasma glucose and glycosylated haemoglobin in diabetic individuals, it has also demonstrated glycaemic indices. Peroxisome Proliferator-Activated Receptor (PPAR)-α/γ agonists found in Lipaglyn Tablets have a significant PPAR-alpha action and a moderate PPAR-gamma effect. PPAR-alpha promotes lipolysis and the hepatic oxidation of fatty acids while decreasing triglyceride production and secretion. Additionally, it causes HDL cholesterol production to rise. PPAR-gamma improves post-absorptive insulin-mediated regulation of hepatic glucose production, increases glucose utilisation, and lessens the metabolic load on the liver and muscle. Lipaglyn tablets help lower blood triglycerides and blood glucose levels because they contain a single chemical that has both lipid and glucose-lowering properties. Additionally, it aids in reducing insulin resistance. Excellent glycaemic control, increased lipid regulation effectiveness, and an improved safety profile are all provided by Lipaglyn Tablet. Do not chew or break the Lipaglyn tablet; instead, swallow it whole with a glass of water. If you have an allergy to any of the ingredients in Lipaglyn Tablet, do not take it. Notify your physician if you experience sudden weight gain. If you are pregnant, speak with your doctor before using Lipaglyn Tablets. Nursing moms should refrain from using Lipaglyn Tablet since it is unknown if it is excreted into breastmilk. Children shouldn’t be given Lipaglyn tablets because their efficacy and safety have not been shown. Lipaglyn tablets may cause vertigo, therefore exercise caution when driving. Avoid drinking alcohol while using Lipaglyn Tablets as it may result in unpleasant side effects. Patients with cardiovascular disease and type-2 diabetes should use Lipaglyn tablets with caution. •Adhere to a diet that lowers cholesterol. •Engage in regular exercise. It reduces cholesterol and aids in keeping a healthy weight. •Limit your intake of sugar and salt. •Steer clear of alcohol and tobacco. •Reduce trans fat and choose healthy fats. •Incorporate foods high in fibre, fruits, vegetables, and omega-3 fatty acids. •Engage in any physical activity to get moving, including jogging, swimming, or brisk walking. Use the stairs rather than the lift or lift. •Try eating meals on a regular basis. Don’t miss meals. Don’t overeat either. •To supplement treatment with Lipaglyn Tablet, walk for at least 45 minutes and maintain a balanced diet. •Get enough sleep and do yoga or meditation to reduce stress. Increased triglyceride, low-density lipoprotein (LDL), and decreased high-density lipoprotein (HDL) levels are the hallmarks of diabetic dyslipidaemia, sometimes referred to as hypertriglyceridemia. People who have type-2 diabetes mellitus frequently have this problem. In those with diabetes, it is one of the main risk factors for cardiovascular disease. Dyslipidaemia may be brought on by lifestyle choices, heredity, obesity, excessive saturated and trans fat intake, low thyroid function, and kidney disease. Chest pain or tightness, indigestion, heartburn, lightheadedness, palpitations, dyspnoea, cold sweats, nausea, and vomiting are all signs of diabetic dyslipidaemia.
Uses of Lipaglyn Tablet
Benefits of Medicine
Instructions for Use
Side Effects of Lipaglyn Tablet
Warnings About Drugs
Advice on Diet and Lifestyle
Glossary of Conditions and Diseases
In Stock
Reviews
There are no reviews yet.